Modifiable risk factors for cardiovascular disease in Iraqi Kurdistan population: a large epidemiological study
https://doi.org/10.4081/hls.2023.12087
Accepted: 27 November 2023
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Cardiovascular diseases (CVDs) are considered the leading factor of morbidity and mortality across the world. This study aimed to identify the modifiable risk factors of CVDs in the Kurdistan Region. In this retrospective cross-sectional study, the patients who visited and were diagnosed with any type of CVDs and treated in a main private cardiac center in Duhok governorate in Kurdistan Region were included between the years 2018 and 2023. The study found a similar percentage of male and female patients. The percentage of old patients was significantly increased from 18-19 to ≥70. The most preventable modifiable risk factors among cardiac patients were hypertension (86.17%), physical inactivity (60.59%), diabetes (40.15%), and dyslipidemia (56.31%). The less preventable modifiable risk factors were alcohol (4.01%) and cigarette smoking (14.43%). Males had a higher prevalence of cigarette smoking (24.63% vs. 4.38%; P<0.0001) and female patients had a higher prevalence of hypertension (91.25% vs. 81.02%; P<0.000), diabetes (44.43% vs. 35.80 %; P=0.0007) and dyslipidemia (59.15% vs. 53.43%; P=0.0257). In terms of family history of heart disease, the middle age group had a higher prevalence compared to younger and older age groups. Diabetes and cigarette smoking was more prevalent among older age groups, while dyslipidemia was more prevalent among younger and older age groups. Alcohol, physical inactivity, and hypertension were similar among age groups. Hypertension, diabetes, dyslipidemia, and physical inactivity were the most prevalent risk factors for CVDs in this region. The older patients had significantly higher rates of some of these risk factors.
Harikrishnan S, Jeemon P, Mini G, et al. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. 2018.
Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 2020;76:2982-3021. DOI: https://doi.org/10.1016/j.jacc.2020.11.010
Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertension Res 2019;42:1235-1481. DOI: https://doi.org/10.1038/s41440-019-0284-9
Collaborators GRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2018;392:1923-94. DOI: https://doi.org/10.1016/S0140-6736(18)32225-6
Mohammad AM, Rashad HH, Habeeb QS, et al. Demographic, clinical and angiographic profile of coronary artery disease in kurdistan region of Iraq. Am J Cardiovasc Dis 2021;11:39.
Mohammad AM, Jehangeer HI, Shaikhow SK. Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq. BMC Cardiovasc Dis 2015;15:1-6. DOI: https://doi.org/10.1186/s12872-015-0145-7
Kurdistan Region Statistics Office. Kurdistan Map, http://www.krso.net/Default.aspx?page=category&c=kurdistan (2015).
Fuchs FD and Whelton PK. High blood pressure and cardiovascular disease. Hypertension 2020;75:285-92. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.119.14240
Liu J, Bu X, Wei L, et al. Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019. J Hypertension 2021;39:2488-96. DOI: https://doi.org/10.1097/HJH.0000000000002958
Oh HJ, Lee S, Lee E-K, et al. Association of blood pressure components with mortality and cardiovascular events in prehypertensive individuals: a nationwide population-based cohort study. Ann Medicine 2018;50:443-52. DOI: https://doi.org/10.1080/07853890.2018.1492146
Lida M, Ueda K, Okayama A, et al. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese--Nippon data 80. J Hum Hypert 2003;17:851-7. DOI: https://doi.org/10.1038/sj.jhh.1001602
Soenarta AA, Buranakitjaroen P, Chia YC, et al. An overview of hypertension and cardiac involvement in Asia: Focus on heart failure. J Clin Hypert 2020;22:423-30. DOI: https://doi.org/10.1111/jch.13753
Wang A, Tian X, Zuo Y, et al. Control of Blood Pressure and Risk of Cardiovascular Disease and Mortality in Elderly Chinese: A Real-World Prospective Cohort Study. Hypertension 2022;79:1866-75. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.122.19587
Aljefree N, Ahmed F. Prevalence of cardiovascular disease and associated risk factors among adult population in the Gulf region: a systematic review. Adv Public Health 2015;2015:1-23. DOI: https://doi.org/10.1155/2015/235101
Stein R, Ferrari F, Scolari F. Genetics, dyslipidemia, and cardiovascular disease: new insights. Curr Cardiol Rep 2019;21:1-12. DOI: https://doi.org/10.1007/s11886-019-1161-5
Chiuve SE, McCullough ML, Sacks FM, et al. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 2006;114:160-7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.621417
Iestra J, Kromhout D, Van der Schouw Y, et al. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation 2005;112:924-34. DOI: https://doi.org/10.1161/CIRCULATIONAHA.104.503995
Leon AS, Bronas UG. Dyslipidemia and risk of coronary heart disease: role of lifestyle approaches for its management. Am J Lifestyle Med 2009;3:257-73. DOI: https://doi.org/10.1177/1559827609334518
World Health Organization. Global recommendations on physical activity for health. World Health Organization, 2010.
Li J, Siegrist J. Physical activity and risk of cardiovascular disease—a meta-analysis of prospective cohort studies. Int J Environ Res Public Health 2012;9:391-407. DOI: https://doi.org/10.3390/ijerph9020391
Jeong S-W, Kim S-H, Kang S-H, et al. Mortality reduction with physical activity in patients with and without cardiovascular disease. Eur Heart J 2019;40:3547-55. DOI: https://doi.org/10.1093/eurheartj/ehz564
Arija V, Villalobos F, Pedret R, et al. Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the “Pas-a-Pas” community intervention trial. BMC Public Health 2017;17:1-11. DOI: https://doi.org/10.1186/s12889-017-4485-3
Lin H, Sardana M, Zhang Y, et al. Association of habitual physical activity with cardiovascular disease risk. Circ Res 2020;127:1253-60. DOI: https://doi.org/10.1161/CIRCRESAHA.120.317578
Edwards P, Tsouros AD. A healthy city is an active city: a physical activity planning guide. World Health Organization. Regional Office for Europe, 2008.
Khattab A, Javaid A, Iraqi G, et al. Smoking habits in the Middle East and North Africa: results of the BREATHE study. Respiratory Med 2012;106:S16-S24. DOI: https://doi.org/10.1016/S0954-6111(12)70011-2
Siziya S, Muula AS, Rudatsikira E. Correlates of current cigarette smoking among in-school adolescents in the Kurdistan region of Iraq. Conflict Health 2007;1:1-7. DOI: https://doi.org/10.1186/1752-1505-1-13
Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. DOI: https://doi.org/10.1016/S0140-6736(04)17018-9
Baba S, Iso H, Mannami T, et al. Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women: the JPHC Study Cohort I. Eur J Preventive Cardiol 2006;13:207-13. DOI: https://doi.org/10.1097/01.hjr.0000194417.16638.3d
Patnode CD, Henderson JT, Coppola EL, et al. Interventions for tobacco cessation in adults, including pregnant persons: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;325:280-98. DOI: https://doi.org/10.1001/jama.2020.23541
Farmanfarma KK, Ansari-Moghaddam A, Zareban I, et al. Prevalence of type 2 diabetes in Middle–East: Systematic review& meta-analysis. Primary Care Diabetes 2020;14:297-304. DOI: https://doi.org/10.1016/j.pcd.2020.01.003
De Rosa S, Arcidiacono B, Chiefari E, et al. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol 2018;9:2. DOI: https://doi.org/10.3389/fendo.2018.00002
Kim HK, Lee JB, Kim SH, et al. Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans. J Diabetes 2016;8:657-66. DOI: https://doi.org/10.1111/1753-0407.12343
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Downloads
Citations
